{"nct_id":"NCT00353574","title":"DORADO-EX: Long-Term Safety Extension Study to the Phase 3 DORADO Study (Protocol DAR-311) of Darusentan in Resistant Hypertension","status":"TERMINATED","status_verified_date":"2014-02","start_date":"2006-09","start_date_type":null,"primary_completion_date":"2010-02","primary_completion_date_type":"ACTUAL","completion_date":"2010-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["GILD"]}